[HTML][HTML] Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale… - Antibiotics, 2024 - mdpi.com
(1) Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale… - ANTIBIOTICS, 2024 - cris.unibo.it
:(1) Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …

[HTML][HTML] Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale… - Antibiotics, 2024 - ncbi.nlm.nih.gov
Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory …

M Gatti, M Rinaldi, T Tonetti… - Antibiotics (2079 …, 2024 - search.ebscohost.com
Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …

[PDF][PDF] Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale… - 2024 - pdfs.semanticscholar.org
(1) Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory …

M Gatti, M Rinaldi, T Tonetti… - Antibiotics (Basel …, 2024 - pubmed.ncbi.nlm.nih.gov
(1) Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi… - Antibiotics (Basel …, 2024 - europepmc.org
Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …

Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi… - Antibiotics (Basel …, 2024 - europepmc.org
(1) Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …

[PDF][PDF] Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and …

M Gatti, M Rinaldi, T Tonetti, A Siniscalchi, P Viale… - 2024 - cris.unibo.it
(1) Background: The advantage of using carbapenems over beta-lactam/beta-lactamase
inhibitor combinations in critically ill septic patients still remains a debated issue. We aimed …